Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
On this final Oncology Onward episode of 2023, cohosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, talk with Penn Medicine’s Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation. Their conversation encapsulates much of what has been discussed in the oncology space in the past year, from the unique perspective of academic medicine: the importance of collaboration between academic medical centers and community oncology practices and testing innovative cancer care delivery in academic and community settings to have the greatest impact on patients.
“If we can only show that a certain innovation works at Penn Medicine or an academic practice, it's very limited—it's useful, but it's very limited,” Bekelman says. “If we want to demonstrate as part of our mandate to generalize knowledge across the country, we have to be able to extend programs into the community, learn from the community, test things that are working in the community in academic environments, create a bidirectional approach that allows for expertise from both systems to create the best possible opportunities for patients with cancer.”
For interview audio:
Listen above or on one of these podcast services:
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More